ESPNL p.Pro689Leu
c.2066C>T · VCV4019801
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0778 | likely benign |
|---|---|---|
| REVEL | 0.1 | moderately benign-leaning |
| SaProt | LLR -7.15 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.42 | GERP -0.57 |
| Regional constraint | o/e 1.07 | unconstrained · MANE · 31 kb · p 0.0064 · regional, not allelic |
| Overall | ||
| CADD | 2.135 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.00767% | 13,033 |
| Remaining individualsnot grpmax-eligible | 0.00166% | 60,136 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ESPNL
- Protein
- p.Pro689Leu
- Coding
- c.2066C>T
- MANE Select
- NM_194312
- Type
- single nucleotide variant
- Location
- chr2:238130780 (GRCh38)
- Gene constraint
- LOEUF 1.651 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 65.57
Similar variants
- ESPNL p.Arg167Gln Benign ★★ same type
- ESPNL p.Arg351Cys Benign ★★ ⚠ same type
- ESPNL c.672+1G>A Uncertain significance ★ same type
- ESPNL p.Ala112Ser Uncertain significance ★ ⚠ same type
- ESPNL p.Ala144Asp Uncertain significance ★ ⚠ same type
- ESPNL p.Ala144Thr Uncertain significance ★ ⚠ same type
- ESPNL p.Ala145Thr Uncertain significance ★ ⚠ same type
- ESPNL p.Ala159Thr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/espnl-p-pro689leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown